previous compound ID: 337 next compound
InChIKey: CHDPSNLJFOQTRK-UHFFFAOYSA-N
SMILES: CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"E Matthes" "SD Macknight" "J Goepp" "J Liao" "D Rotin" "R Robert" "B Kus" "JW Hanrahan" "DY Thomas" "GW Carlile"

chemical graph of compound 337





CID is 107952
synonyms found at PubChem are:
Betaxolol hydrochloride, 63659-19-8, Betaxolol HCL, Betoptima, Kerlone, Lokren, Betoptic, Kerlon, Betaxolo Hydrochloride, Betoptic S, Betaxolol (hydrochloride), alo 1401-02, EINECS 264-384-3, MLS000863279, SL 75 212-10, Betaxolol hydrochloride (Betoptic), CPD000058420, SMR000058420, Betoptic (TN), Kerlone (TN), SL 75.212-10, (+-)-1-(p-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-(isopropylamino)-2-propanol hydrochloride, 1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-isopropylaminopropan-2-ol hydrochloride, 1-(isopropylamino)-3-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]propan-2-ol hydrochloride, Q-200714, 1-(Isopropylamino)-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol hydrochloride, 2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, hydrochloride, (+-)-, CHEBI:643228, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol hydrochloride, SR-01000000108, SL-75212-10, Kerlong, Betaxolol hydrochloride [USAN], 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride, Prestwick_779, Betaxolol hydrochloride [USAN:USP:JAN], Betaxolol(hydrochloride), Opera_ID_878, Lokren ,Kerlone ;Betoptic, AC1Q3DQ4, CHEMBL1691, SCHEMBL42794, MLS000028464, MLS000758269, MLS001148209, MLS001424199, MLS002222261, AC1L331T, CTK8F0839, HY-B0381A, MCI-144, CHDPSNLJFOQTRK-UHFFFAOYSA-N, MolPort-003-666-823, HMS1569M05, Pharmakon1600-01505512, 63659-18-7 (Parent), BCP02967, Tox21_500193, Betaxolol hydrochloride (JP17/USP), BG0105, MFCD00242959, NSC760048, AKOS015843993, AC-1412, API0001701, BCP9000394, CCG-101057, CCG-213473, CS-2453, LP00193, NC00307, NSC-760048, Betaxolol hydrochloride, >98% (HPLC), KS-00001F73, NCGC00093669-01, NCGC00093669-02, NCGC00260878-01, AN-14973, AS-18082, BC227944, SAM001247084, BCP0726000249, AB2000314, LS-122006, TC-071428, B4474, EU-0100193, FT-0645228, S1827, W0012, B 5683, D00598, 659X198, A803574, I06-1154, SR-01000000108-2, SR-01000000108-4, SR-01000000108-9, Betaxolol hydrochloride, European Pharmacopoeia (EP) Reference Standard, Betaxolol hydrochloride, United States Pharmacopeia (USP) Reference Standard, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol hydrochloride, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)-2-propanol hydrochloride, 1-[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-3-isopropylamino-2-propanol hydrochloride, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-isopropylamino-2-propanolhydrochloride, Betaxolol for peak identification, European Pharmacopoeia (EP) Reference Standard, 2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-,hydrochloride, 72424-72-7, AC1LCWB4, AKOS026749833, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol; hydron; chloride, 1-(isopropylamino)-3-[p-(cyclopropylmethoxyethyl)phenoxy]-2-propanol hydrochloride, 1-(p-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-(isopropylamino)-2-propanol hydrochloride, 3-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-2-hydroxy-N-(propan-2-yl)propan-1-aminium chloride, 1-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-3-(propan-2-ylamino)propan-2-ol hydrochloride, MolPort-005-977-072, MCULE-2260668292, 1-[4-(2-Cyclopropylmethoxy-ethyl)-phenoxy]-3-isopropylamino-propan-2-ol; hydrochloride